Immuno-inflammatory-related vulnerabilities and high mortality risk among patients with aggressive early-onset epithelial ovarian cancers in West Africa

IntroductionThis study evaluated systemic immune-inflammatory indices (SIII) among patients with epithelial ovarian cancer (EOC) to identify affordable markers for disease assessment and treatment monitoring. This study did not assess the rate of BRCA2 mutation and SIII in early-onset ([≤] 50 years old) and late-onset (> 50 years old) EOC but... Show more